Becton Dickinson vs Abbott Laboratories vs Baxter International and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Becton Dickinson 4.983, Abbott Laboratories 12.593, Baxter International 2.96, Boston Scientific 5.442.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Becton Dickinson, Abbott Laboratories, Baxter International, Boston Scientific.| Metric | Becton Dickinson | Abbott Laboratories | Baxter International | Boston Scientific |
|---|---|---|---|---|
| Market Cap | $51.81B | $197.44B | $13.70B | $69.81B |
| Revenue | $4.98B | $12.59B | $2.96B | $5.44B |
| Cost of Revenue | $2.67B | $5.29B | $1.93B | $1.59B |
| Gross Profit | $2.31B | $7.30B | $1.03B | $3.85B |
| Operating Income | $663.00M | $1.78B | $217.00M | $1.18B |
| Net Income | $377.00M | $928.00M | $126.00M | $907.00M |
| R&D Expense | $258.00M | $882.00M | $129.00M | $554.00M |
| Earnings Per Share | $1.37 | $0.53 | $0.24 | $0.61 |
| Gross Margin | 46.5% | 58.0% | 34.9% | 70.7% |
| Operating Margin | 13.3% | 14.2% | 7.3% | 21.6% |
| Net Profit Margin | 7.6% | 7.4% | 4.3% | 16.7% |
| Free Cash Flow | $509.00M | $2.89B | $32.00M | $1.28B |
| Cumulative Free Cash Flow | $39.60B | $142.48B | $35.82B | $27.75B |
| Operating Cash Flow | $652.00M | $2.49B | $285.00M | $1.47B |
| Cash & Equivalents | $708.00M | $5.10B | $2.15B | $539.00M |